Evidence map›Paper›PMID 30467136›Full record

ArticleBMJ open2018

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan.

Abdallah Y Naser, Ian Chi Kei Wong, Cate Whittlesea, Maedeh Y Beykloo, Kenneth K C Man, Wallis C Y Lau, Dana Abdel-Halim Hyassat, Li Wei

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The safety and efficacy of the use of oral anticoagulant medications in patients with diabetes mellitus: A systematic review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Abdallah Y NaserResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Ian Chi Kei WongResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Cate WhittleseaResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Maedeh Y BeyklooResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Kenneth K C ManResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Wallis C Y LauResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Dana Abdel-Halim HyassatNational Centre for Diabetes, Endocrinology and Genetics, Amman, Jordan.
Li WeiResearch Department of Practice and Policy, UCL School of Pharmacy, London, UK.
University College London · GBUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess whether the use of multiple antidiabetic medications is associated with an increased risk of hypoglycaemia in patients with type 2 diabetes mellitus.

designA case-crossover study.

settingCases were enrolled from the National Center for Diabetes, Endocrinology and Genetics in Amman, Jordan.

participantsPatients were those with diabetes mellitus and reported incident of a hypoglycaemic event in their medical records during the period January 2007 to July 2017. Patients with multiple antidiabetic medications were those with at least two antidiabetic medications. PRIMARY OUTCOME: History of antidiabetic medication use was extracted from the pharmacy records. The use of multiple antidiabetic medications during the risk window (before hypoglycaemia) was compared with a control window(s) (earlier time) of the same length after a washout period. Conditional logistic regression was applied to evaluate the OR of hypoglycaemia between the treatment groups. A secondary analysis was performed in patients with a blood glucose measurement of ≤70 mg/dL.

results182 patients (106 females, 58.2%) were included in the study with an average age of 59.9 years (SD=9.9). The patients' average body mass index was 31.7 kg/m

conclusionThis study shows that the use of multiple antidiabetic medications appears to increase the risk of hypoglycaemic events. Patients and healthcare professionals should be extra vigilant when patients are on multiple antidiabetic medications therapy, especially the combination of sulfonylurea and insulin.

Indexed as

Developing CountriesAgedCase-Control StudiesDiabetes Mellitus, Type 2Drug Therapy, CombinationFemaleHumansHypoglycemiaHypoglycemic AgentsJordanMaleMiddle AgedRisk AssessmentHypoglycemic Agentsantidiabetic medicationscase-crossoverhypoglycaemiceventsmultiple medications

Identifiers

PMID30467136
PMCPMC6252777
OpenAlexW2901562016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.